DarioHealth (DRIO) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
29 Dec, 2025Management team and governance
CEO is Erez Raphael, who also serves as principal executive officer.
Chen Franco-Yehuda is the Chief Financial Officer, Secretary, and Treasurer, acting as principal financial and accounting officer.
Board includes Yoav Shaked (Chairman), Lawrence Leisure, Hila Karah, Dennis Matheis, Dennis M. McGrath, and Adam Stern.
All signatures for the registration statement were executed on December 29, 2025.
Offering details and pricing
Registration statement filed as Form S-3/A for a shelf offering, allowing securities to be offered from time to time after effectiveness.
Securities may be offered on a delayed or continuous basis under Rule 415.
The amendment was filed to update Exhibit 23.1 and restate the exhibit index.
Underwriters and syndicate
Legal counsel includes Sullivan & Worcester LLP, with Oded Har-Even and Ron Ben-Bassat as contacts.
Latest events from DarioHealth
- Registering up to $100M in securities to support growth and innovation in digital health.DRIO
Registration filing19 Mar 2026 - Record new business, margin expansion, and a $122M pipeline set up for accelerated 2026 growth.DRIO
Q4 202519 Mar 2026 - B2B2C revenue surged 315% year-over-year, driving margin gains and a path to breakeven by 2025.DRIO
Q2 20242 Feb 2026 - Q3 revenue up 111% YoY, but cash shortfall and delisting risk threaten future viability.DRIO
Q3 202416 Jan 2026 - 2024 revenue up 32.9% to $27M, net loss narrowed, breakeven targeted for 2025.DRIO
Q4 202426 Dec 2025 - Annual meeting seeks approval for director elections, auditor, equity plan, and charter amendment.DRIO
Proxy Filing22 Dec 2025 - 52.1M shares registered for resale; no proceeds to company; focus on AI-driven digital health.DRIO
Registration Filing16 Dec 2025 - 2.7 million shares registered for resale; no proceeds to company; focus on AI-driven health platform.DRIO
Registration Filing16 Dec 2025 - Registering 8.77M shares for resale, company faces losses and geopolitical risks, with AI-driven health focus.DRIO
Registration Filing16 Dec 2025